Top Markets
Coin of the day
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Pozycja w akcjach #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Cena akcji
$0.00953895
Ostatnia synchronizacja: 2024-05-22
Kapitalizacja rynkowa
$1.28M
Zmiana (1 dzień)
0.06%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel Evgen Pharma plc (EVG)

Kategoria

Historia ceny akcji dla Evgen Pharma plc (EVG)
Najwyższa cena zamknięcia: $0.01 dnia 2024-05-01

Najniższa cena zamknięcia: $0.49 dnia 2015-10-01
Historia cen akcji firmy Evgen Pharma plc od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 -54.58%
2023 -67.00%
2022 -8.24%
2021 -46.45%
2020 34.51%
2019 -54.10%
2018 2.85%
2017 -28.77%
2016 -24.59%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE